WallStreetZenWallStreetZen

NASDAQ: TARA
Protara Therapeutics Inc Stock Ownership - Who owns Protara Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Protara Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jacqueline ZummoChf Scientific Operations Off2024-01-193,049$1.91
$5.82kSell
Jesse SheffermanCEO and President2024-01-197,803$1.91
$14.90kSell
Jathin BandariChief Medical Officer2024-01-192,879$1.91
$5.50kSell
Hannah FryVP Controller2024-01-19904$1.91
$1.73kSell
Jathin BandariChief Medical Officer2024-01-101,877$2.39
$4.49kSell
Jacqueline ZummoChf Scientific Operations Off2024-01-105,229$2.39
$12.50kSell
Jesse SheffermanCEO and President2024-01-105,746$2.39
$13.73kSell
Jesse SheffermanCEO and President2024-01-035,840$2.17
$12.67kSell
Hannah FryVP Controller2024-01-03324$2.17
$703.08Sell
Jacqueline ZummoChf Scientific Operations Off2024-01-031,899$2.17
$4.12kSell

1 of 2

TARA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TARA insiders and whales buy or sell their stock.

TARA Shareholders

What type of owners hold Protara Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Hubert Birner49.26%5,632,802$16.90MInsider
Abingworth LLP36.40%4,162,389$12.49MInsider
Tvm Life Science Ventures Vi Gmbh Co Kg33.64%3,846,186$11.54MInsider
John Gordon Freund31.56%3,608,812$10.83MInsider
Opaleye Management Inc23.55%2,692,594$8.08MInsider
Opaleye Management Inc23.55%2,692,594$8.08MInstitution
James E. Flynn21.19%2,422,745$7.27MInsider
Timothy Haines18.76%2,144,517$6.43MInsider
Skyline Venture Partners Qualified Purchaser Fund Iv L P12.53%1,432,930$4.30MInsider
Brendan Oleary12.13%1,387,198$4.16MInsider

1 of 3

TARA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TARA11.95%88.05%Net SellingNet Selling
IPA6.56%0.00%
JAGX0.45%3.88%
APRE1.54%98.46%Net BuyingNet Buying
ACST6.08%64.72%Net Buying
View Top Biotech Stocks

Protara Therapeutics Stock Ownership FAQ

Who owns Protara Therapeutics?

Protara Therapeutics (NASDAQ: TARA) is owned by 38.12% institutional shareholders, 280.82% Protara Therapeutics insiders, and 0.00% retail investors. Hubert Birner is the largest individual Protara Therapeutics shareholder, owning 5.63M shares representing 49.26% of the company. Hubert Birner's Protara Therapeutics shares are currently valued at $16.00M.

If you're new to stock investing, here's how to buy Protara Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.